Begin typing your search...
WHO sets dates for reviews of Sinopharm and Sinovac COVID-19 vaccines
"We would expect a decision a couple of days later," the WHO said in response to a Reuters query.
Geneva
Technical experts at the World Health Organization (WHO) will review on April 26 Chinese drugmaker Sinopharm's COVID-19 vaccine for possible emergency use listing, to be followed by the Sinovac jab on May 3, the agency said on Thursday. "We would expect a decision a couple of days later," the WHO said in response to a Reuters query.
So far COVID-19 vaccines made by Pfizer AstraZeneca and Johnson & Johnson have received a WHO listing - an endorsement of their safety and efficacy that helps to guide countries' regulatory agencies.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android
Next Story